Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy [NA]

View source ↗

Summary

This clinical trial update announces recruiting status for a study evaluating the nutritional outcomes of lotus seed (Nelumbo nucifera) on diabetic sensorimotor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lotus seed (Nelumbo nucifera) (Nelumbo nucifera seed)

Snippet

Sponsor: Riphah International University | Conditions: Diabetes Mellitus, Type 2, Diabetic Nephropathies | NA | Status: RECRUITING